Phospho-USP22 (Thr147) Antibody - #AF7076
| Product: | Phospho-USP22 (Thr147) Antibody |
| Catalog: | AF7076 |
| Description: | Rabbit polyclonal antibody to Phospho-USP22 (Thr147) |
| Application: | WB IHC |
| Reactivity: | Human, Mouse, Rat |
| Prediction: | Pig, Zebrafish, Bovine, Horse, Rabbit, Dog, Chicken, Xenopus |
| Mol.Wt.: | 66kDa; 60kD(Calculated). |
| Uniprot: | Q9UPT9 |
| RRID: | AB_2843516 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF7076, RRID:AB_2843516.
Fold/Unfold
Deubiquitinating enzyme 22; KIAA1063; Ubiquitin carboxyl terminal hydrolase 22; Ubiquitin carboxyl-terminal hydrolase 22; Ubiquitin specific peptidase 22; Ubiquitin specific peptidase 3 like; Ubiquitin specific processing protease 22; Ubiquitin specific protease 22; Ubiquitin thioesterase 22; Ubiquitin thiolesterase 22; Ubiquitin-specific-processing protease 22; UBP22_HUMAN; USP 22; Usp22; USP3L;
Immunogens
Moderately expressed in various tissues including heart and skeletal muscle, and weakly expressed in lung and liver.
- Q9UPT9 UBP22_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MVSRPEPEGEAMDAELAVAPPGCSHLGSFKVDNWKQNLRAIYQCFVWSGTAEARKRKAKSCICHVCGVHLNRLHSCLYCVFFGCFTKKHIHEHAKAKRHNLAIDLMYGGIYCFLCQDYIYDKDMEIIAKEEQRKAWKMQGVGEKFSTWEPTKRELELLKHNPKRRKITSNCTIGLRGLINLGNTCFMNCIVQALTHTPLLRDFFLSDRHRCEMQSPSSCLVCEMSSLFQEFYSGHRSPHIPYKLLHLVWTHARHLAGYEQQDAHEFLIAALDVLHRHCKGDDNGKKANNPNHCNCIIDQIFTGGLQSDVTCQVCHGVSTTIDPFWDISLDLPGSSTPFWPLSPGSEGNVVNGESHVSGTTTLTDCLRRFTRPEHLGSSAKIKCSGCHSYQESTKQLTMKKLPIVACFHLKRFEHSAKLRRKITTYVSFPLELDMTPFMASSKESRMNGQYQQPTDSLNNDNKYSLFAVVNHQGTLESGHYTSFIRQHKDQWFKCDDAIITKASIKDVLDSEGYLLFYHKQFLEYE
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q9UPT9 As Substrate
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| K35 | Ubiquitination | Uniprot | |
| K59 | Ubiquitination | Uniprot | |
| K95 | Ubiquitination | Uniprot | |
| K129 | Acetylation | Uniprot | |
| K129 | Sumoylation | Uniprot | |
| K129 | Ubiquitination | Uniprot | |
| K137 | Sumoylation | Uniprot | |
| K137 | Ubiquitination | Uniprot | |
| K144 | Ubiquitination | Uniprot | |
| S146 | Phosphorylation | Uniprot | |
| T147 | Phosphorylation | Uniprot | |
| T151 | Phosphorylation | Uniprot | |
| K152 | Sumoylation | Uniprot | |
| K152 | Ubiquitination | Uniprot | |
| K159 | Ubiquitination | Uniprot | |
| K166 | Acetylation | Uniprot | |
| K166 | Ubiquitination | Uniprot | |
| R208 | Methylation | Uniprot | |
| Y232 | Phosphorylation | Uniprot | |
| S237 | Phosphorylation | Uniprot | |
| K380 | Ubiquitination | Uniprot | |
| K382 | Sumoylation | Uniprot | |
| K382 | Ubiquitination | Uniprot | |
| K394 | Ubiquitination | Uniprot | |
| K410 | Ubiquitination | Uniprot | |
| K417 | Acetylation | Uniprot | |
| K417 | Sumoylation | Uniprot | |
| K417 | Ubiquitination | Uniprot | |
| T423 | Phosphorylation | Uniprot | |
| K442 | Ubiquitination | Uniprot | |
| S444 | Phosphorylation | Uniprot | |
| Y450 | Phosphorylation | Uniprot | |
| K462 | Sumoylation | Uniprot | |
| K462 | Ubiquitination | Uniprot | |
| R485 | Methylation | Uniprot | |
| K488 | Ubiquitination | Uniprot | |
| K493 | Ubiquitination | Uniprot | |
| K501 | Ubiquitination | Uniprot | |
| K505 | Ubiquitination | Uniprot |
Research Backgrounds
Histone deubiquitinating component of the transcription regulatory histone acetylation (HAT) complex SAGA. Catalyzes the deubiquitination of both histones H2A and H2B, thereby acting as a coactivator. Recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Required for nuclear receptor-mediated transactivation and cell cycle progression.
Nucleus.
Moderately expressed in various tissues including heart and skeletal muscle, and weakly expressed in lung and liver.
Component of some SAGA transcription coactivator-HAT complexes, at least composed of ATXN7, ATXN7L3, ENY2, GCN5L2, SUPT3H, TAF10, TRRAP and USP22. Within the SAGA complex, ATXN7L3, ENY2 and USP22 form a subcomplex required for histone deubiquitination. Interacts directly with ATXN7L3; leading to its recruitment to the SAGA complex. Interacts with ATXN7L3 and weakly with ATXN7L3B.
Belongs to the peptidase C19 family. UBP8 subfamily.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.